Preclinical data suggest WRN inhibitor may be viable treatment for MSI-H tumors

Rathmell steps down at NCI as Trump team considers candidates to replace her
Wafik El-Deiry, Harvey Risch have been interviewed

W. Kimryn Rathmell has stepped down as NCI director, opting to hand her resignation to the Biden administration over facing the uncertainties that Trump and his team are expected to usher in starting next week.

Report shows UPMC Hillman’s nearly $4B economic impact in Pennsylvania

A recent report showed that UPMC Hillman Cancer Center generated $3.98 billion in total economic impact in Pennsylvania through its clinical, research, and educational missions in 2023.

January 17, 2025

Vol.51 No.02

Clinical Roundup

Epigenetic research reveals a potential treatment for CRC and other solid tumors

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new study from researchers at the Johns Hopkins Kimmel Cancer Center and the Chinese Academy of Sciences.

January 17, 2025

Vol.51 No.02

The Human Tumor Atlas Network charts the roadmap for advancing spatial omics

The NCI Human Tumor Atlas Network (HTAN) has published a cluster of papers intended to advance the framework of spatial omics, the science of profiling morphological and molecular features of human cancers in two and three dimensions.

Moving from mandate to mission: Community outreach and engagement at NCI-designated cancer centers
“COE is broken.”

Acting Director Dr. Krzysztof Ptak’s words reverberated throughout the meeting room—and the heads of several of us—during the National Cancer Institute’s Office of Cancer Centers update on the final day of the 2024 Association of American Cancer Institutes/Cancer Center Administrators Forum Annual Meeting in Chicago.

December 13, 2024

Vol.50 No.46

By Monica L. Baskin, Nadine J. Barrett, Kim F. Rhoads, Hayley S. Thompson, Kimlin Tam Ashing, Folakemi T. Odedina and Vanessa B. Sheppard

BSA approves four new, five reissue concepts

The NCI Board of Scientific Advisors approved four new concepts and five reissue concepts at a joint meeting of the BSA and the National Cancer Advisory Board Dec. 2-3.

December 13, 2024

Vol.50 No.46

By Jacquelyn Cobb and Claire Marie Porter

Preclinical data suggest WRN inhibitor may be viable treatment for MSI-H tumors

YOU MAY BE INTERESTED IN

Rathmell steps down at NCI as Trump team considers candidates to replace her
Wafik El-Deiry, Harvey Risch have been interviewed

Report shows UPMC Hillman’s nearly $4B economic impact in Pennsylvania

Epigenetic research reveals a potential treatment for CRC and other solid tumors

The Human Tumor Atlas Network charts the roadmap for advancing spatial omics

Moving from mandate to mission: Community outreach and engagement at NCI-designated cancer centers
“COE is broken.”

BSA approves four new, five reissue concepts

Renew today!

Subscriber content

Never miss an issue!

Login

Preclinical data suggest WRN inhibitor may be viable treatment for MSI-H tumors

YOU MAY BE INTERESTED IN

Rathmell steps down at NCI as Trump team considers candidates to replace herWafik El-Deiry, Harvey Risch have been interviewed

Report shows UPMC Hillman’s nearly $4B economic impact in Pennsylvania

Epigenetic research reveals a potential treatment for CRC and other solid tumors

The Human Tumor Atlas Network charts the roadmap for advancing spatial omics

Moving from mandate to mission: Community outreach and engagement at NCI-designated cancer centers“COE is broken.”

BSA approves four new, five reissue concepts

Never miss an issue!

Login

Rathmell steps down at NCI as Trump team considers candidates to replace her
Wafik El-Deiry, Harvey Risch have been interviewed

Moving from mandate to mission: Community outreach and engagement at NCI-designated cancer centers
“COE is broken.”